ENvue Medical Secures USPTO Patent Allowance for Ultrasound-Enhanced Cannabinoid Transdermal Delivery System
The granted patent expands ENvue’s proprietary surface acoustic wave technology into cannabinoid therapeutics, potentially enabling new drug delivery applications and strategic co…
ENvue Medical announced that the USPTO has issued a Notice of Allowance for its patent application covering a surface acoustic wave (SAW) ultrasound system designed to enhance transdermal delivery of cannabinoid-based drugs. This patent broadens ENvue’s intellectual property portfolio beyond its existing feeding tube…